Investment
Features
FeesSafety
Academy
More
Pluang+

Compare F5 Inc (FFIV) vs GeneDx Holdings Corp (WGS) Price & Performance

GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

F5 Inc vs GeneDx Holdings Corp — how do they compare? F5 Inc trades at $414 (market cap $23.44B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: F5 Inc is far larger — about 9.6× GeneDx Holdings Corp's market cap, and F5 Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.

FFIVWGS
Market Cap
$23.44B$2.44B
Sector
TechnologyTechnology
52-Week High
$431.26$167.51
52-Week Low
$223.99$34.51
Enterprise Value
$22.08B$2.48B

Returns comparison

Trailing returns across standard periods

About F5 Inc

F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.

Read more on FFIV

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS